Diabetic nephropathies Trials in Chicago, United States
Conditions / Diabetic nephropathies / Chicago, United States
Research into Diabetic nephropathies spans multiple therapeutic approaches and trial phases.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01200394 | A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy | COMPLETED | PHASE2 |
| NCT03334318 | PERL Continuous Glucose Monitoring (CGM) Study | COMPLETED | — |
| NCT04387448 | A Study of TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease | TERMINATED | PHASE2 |
| NCT04750577 | A Study to Test the Effect of Different Doses of BI 685509 on Kidney Function in People With Diabetic Kidney Disease | COMPLETED | PHASE2 |
| NCT00168857 | A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study) | COMPLETED | PHASE4 |
| NCT06217302 | Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease | RECRUITING | PHASE3 |
| NCT02986984 | Transformative Research in Diabetic Nephropathy | RECRUITING | — |
| NCT02017171 | A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes | COMPLETED | PHASE3 |
| NCT01874431 | Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy | COMPLETED | PHASE2 |
| NCT03165227 | This Study Tests a New Medicine Called BI 685509 in Patients That Have Kidney Problems Because of Diabetes. The Study Tests How BI 685509 is Taken up in the Body and How Well it is Tolerated (Multiple Rising Doses) | COMPLETED | PHASE1 |